1. A Bayesian adaptive design for cancer phase I trials using a flexible range of doses. Issue 3 (4th May 2018) Authors: Tighiouart, Mourad; Cook-Wiens, Galen; Rogatko, André Journal: Journal of biopharmaceutical statistics Issue: Volume 28:Issue 3(2018) Page Start: 562 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A BAYESIAN ADAPTIVE TWO-STAGE DESIGN FOR PEDIATRIC CLINICAL TRIALS. Issue 6 (1st November 2020) Authors: Psioda, Matthew A.; Xue, Xiaoqiang Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 6(2020) Page Start: 1091 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A Bayesian approach to benefit–risk assessment in clinical studies with longitudinal data. Issue 3 (3rd May 2020) Authors: Yan, Dongyan; Ahn, Chul; Azadeh, Shabnam; Atlas, Mourad; Tiwari, Ram Journal: Journal of biopharmaceutical statistics Issue: Volume 30:Issue 3(2020) Page Start: 574 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A Bayesian equivalency test for two independent binomial proportions. Issue 4 (3rd July 2016) Authors: Kawasaki, Yohei; Shimokawa, Asanao; Yamada, Hiroshi; Miyaoka, Etsuo Journal: Journal of biopharmaceutical statistics Issue: Volume 26:Issue 4(2016) Page Start: 781 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. A Bayesian group sequential design for randomized biosimilar clinical trials with adaptive information borrowing from historical data. Issue 3 (4th May 2022) Authors: Zhang, Wen; Pan, Zhiying; Yuan, Ying Journal: Journal of biopharmaceutical statistics Issue: Volume 32:Issue 3(2022) Page Start: 359 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. A Bayesian Meta-analysis Method for Estimating Risk Difference of Rare Events. Issue 3 (4th May 2018) Authors: Tang, Yuanyuan; Tang, Qi; Yu, Yao; Wen, Shihua Journal: Journal of biopharmaceutical statistics Issue: Volume 28:Issue 3(2018) Page Start: 550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. A Bayesian model for combining standardized mean differences and odds ratios in the same meta-analysis. Issue 2 (4th March 2023) Authors: Jing, Yaqi; Murad, Mohammad Hassan; Lin, Lifeng Journal: Journal of biopharmaceutical statistics Issue: Volume 33:Issue 2(2023) Page Start: 167 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. A Bayesian paradigm for decision-making in proof-of-concept trials. Issue 3 (4th May 2017) Authors: Pulkstenis, Erik; Patra, Kaushik; Zhang, Jianliang Journal: Journal of biopharmaceutical statistics Issue: Volume 27:Issue 3(2017) Page Start: 442 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A Bayesian three-parameter logistic model for early- and late-onset DLTs in oncology Phase I studies. Issue 2 (3rd March 2016) Authors: Zheng, Wei; Zhao, Yang; Lu, Yuefeng; Miao, Harry; Liu, Hengchang Journal: Journal of biopharmaceutical statistics Issue: Volume 26:Issue 2(2016) Page Start: 339 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. A Bayesian three-tier quantitative decision-making framework for single arm studies in early phase oncology. Issue 1 (2nd January 2023) Authors: Liu, Zhuqing; Liu, Jingyi; Xia, Meng Journal: Journal of biopharmaceutical statistics Issue: Volume 33:Issue 1(2023) Page Start: 60 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗